ALK and neoplasm: The combined analysis of PD-L1 and CD8+ TILs showed a significantly higher proportion of PD-L1-/TIL- tumours and a lower proportion of PD-L1+/TIL+ tumours in ALK-positive patients than in ALK-negative patients [33].